TAIPEI, March 17, 2025 /PRNewswire/ -- Microbio Co., Ltd. (TPEx: 4128) today announced promising results from an exploratory clinical trial assessing MS-20 in combination with current medications for ...

Visit a quote page and your recently viewed tickers will be displayed here.

Microbio (4128) has delivered a -38.41% change over the past year, with a 52-week range between 17.90 and 35.65. What Is the Average Daily Trading Volume of Microbio (4128)? The average daily trading ...

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today announced that is has signed a worldwide exclusive licensing agreement with Oneness Biotech (Taiwan, ...

Brisbane medtech scale-up Microbio has developed a game-changing pathogen test to help identify “a silent killer” that is notoriously difficult to predict, diagnose and treat, as the signs and ...

4147.TWO TaiMed Biologics Inc.

Microbio (Shanghai) Co. Ltd. has synthesized glucagon-like peptide 1 receptor (GLP1R) agonists reported to be useful for the treatment of obesity, type 2 diabetes and nonalcoholic fatty liver disease.

TAIPEI, May 16, 2025 /PRNewswire/ -- The broad-spectrum antiviral siRNA drug SNS812, co-developed by Oneness Biotech (4743.TW) and Microbio (Shanghai), has been selected for oral presentation at the ...

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer ...

Visit a quote page and your recently viewed tickers will be displayed here.